Bain Capital Private Equity
Private equity
Active
Boston, United States
17
226M
16
0.42
4
0.06
8
- Areas of investment
Summary
The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.
Among the most successful fund investment fields, there are Health Care, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Cerevel Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
Besides them, we counted 9 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 1 participant. Despite the Bain Capital Private Equity, startups are often financed by Silicon Valley Bank, Farnam Street Financial, Bain Capital Ventures. In the next rounds fund is usually obtained by Silicon Valley Bank, Oxford Finance LLC.
The typical startup value when the investment from Bain Capital Private Equity is 100-500 millions dollars. This Bain Capital Private Equity works on 4 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018. The common things for fund are deals in the range of more than 100 millions dollars. Considering the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 17
- Lead investments
- 4
- Exits
- 8
- Rounds per year
- 0.42
- Follow on index
- 0.06
- Investments by industry
- Health Care (6)
- Manufacturing (4)
- Medical Device (3)
- Machine Learning (3)
- Enterprise Software (3) Show 40 more
- Investments by region
-
- United States (12)
- China (3)
- Japan (1)
- Switzerland (1)
- Peak activity year
- 2022
- Number of Unicorns
- 4
- Number of Decacorns
- 4
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 450M
- Group Appearance index
- 0.47
- Avg. company exit year
- 13
- Avg. multiplicator
- 0.72
- Strategy success index
- 0.80
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| EcoCeres | 24 Feb 2022 | Manufacturing, Sustainability, Chemical | Early Stage Venture | 108M | Hong Kong, Kowloon, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.